Search results
Results From The WOW.Com Content Network
Ulotaront ( INN; [ 1] developmental codes SEP-363856, SEP-856) is an investigational antipsychotic that is undergoing clinical trials for the treatment of schizophrenia and Parkinson's disease psychosis. [ 2][ 3] The medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals [ 2] (which was subsequently ...
Size of this JPG preview of this PDF file: 420 × 600 pixels. Other resolutions: 168 × 240 pixels | 336 × 480 pixels | 537 × 768 pixels | 1,050 × 1,500 pixels .
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Pages for logged out editors learn more
File:98-856 (IA 98-856-crs).pdf. Size of this JPG preview of this PDF file: 424 × 600 pixels. Other resolutions: 170 × 240 pixels | 339 × 480 pixels | 543 × 768 pixels | 1,239 × 1,752 pixels. This is a file from the Wikimedia Commons. Information from its description page there is shown below.
This United States Congress image is in the public domain.This may be because it was taken by an employee of the Congress as part of that person’s official duties, or because it has been released into the public domain and posted on the official websites of a member of Congress.
United Nations Security Council resolution 856, adopted unanimously on 10 August 1993, after reaffirming Resolution 813 (1993) and welcoming a peace agreement signed, under the auspices of the Economic Community of West African States (ECOWAS), between the Interim Government of National Unity of Liberia (IGNU), the National Patriotic Front of ...
You are free to: copy, publish, distribute and transmit the Information; adapt the Information; exploit the Information commercially and non-commercially for example, by combining it with other Information, or by including it in your own product or application. You must, where you do any of the above:
You are free to: copy, publish, distribute and transmit the Information; adapt the Information; exploit the Information commercially and non-commercially for example, by combining it with other Information, or by including it in your own product or application. You must, where you do any of the above: